Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EBITDA 2010-2025 | BMY

Bristol Myers Squibb annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Bristol Myers Squibb EBITDA for the quarter ending March 31, 2025 was $3.982B, a 144.32% decline year-over-year.
  • Bristol Myers Squibb EBITDA for the twelve months ending March 31, 2025 was $14.187B, a 253.17% increase year-over-year.
  • Bristol Myers Squibb 2024 annual EBITDA was $1.221B, a 93.29% decline from 2023.
  • Bristol Myers Squibb 2023 annual EBITDA was $18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 annual EBITDA was $17.989B, a 4.23% decline from 2021.
  
Bristol Myers Squibb Annual EBITDA
(Millions of US $)
2024 $1,221
2023 $18,200
2022 $17,989
2021 $18,784
2020 $3,509
2019 $6,721
2018 $6,605
2017 $5,920
2016 $6,297
2015 $2,453
2014 $2,848
2013 $3,654
2012 $5,143
2011 $7,609
2010 $6,678
2009 $6,027
Bristol Myers Squibb Quarterly EBITDA
(Millions of US $)
2025-03-31 $3,982
2024-12-31 $2,055
2024-09-30 $4,268
2024-06-30 $3,882
2024-03-31 $-8,984
2023-12-31 $4,138
2023-09-30 $4,572
2023-06-30 $4,291
2023-03-31 $5,199
2022-12-31 $4,380
2022-09-30 $4,797
2022-06-30 $4,541
2022-03-31 $4,271
2021-12-31 $4,437
2021-09-30 $4,884
2021-06-30 $4,265
2021-03-31 $5,198
2020-12-31 $-7,761
2020-09-30 $4,912
2020-06-30 $4,185
2020-03-31 $2,173
2019-12-31 $1,107
2019-09-30 $1,520
2019-06-30 $1,945
2019-03-31 $2,149
2018-12-31 $1,677
2018-09-30 $2,332
2018-06-30 $674
2018-03-31 $1,922
2017-12-31 $895
2017-09-30 $1,371
2017-06-30 $1,506
2017-03-31 $2,148
2016-12-31 $1,208
2016-09-30 $1,664
2016-06-30 $1,705
2016-03-31 $1,720
2015-12-31 $-334
2015-09-30 $1,092
2015-06-30 $143
2015-03-31 $1,552
2014-12-31 $43
2014-09-30 $1,120
2014-06-30 $483
2014-03-31 $1,202
2013-12-31 $1,050
2013-09-30 $998
2013-06-30 $719
2013-03-31 $887
2012-12-31 $1,004
2012-09-30 $766
2012-06-30 $1,207
2012-03-31 $2,166
2011-12-31 $1,863
2011-09-30 $1,853
2011-06-30 $1,974
2011-03-31 $1,919
2010-12-31 $1,654
2010-09-30 $1,749
2010-06-30 $1,722
2010-03-31 $1,553
2009-12-31 $1,434
2009-09-30 $1,658
2009-06-30 $1,596
2009-03-31 $1,339
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.687B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $221.620B 16.54
Amgen (AMGN) United States $156.214B 13.99
Gilead Sciences (GILD) United States $138.984B 14.44
Vertex Pharmaceuticals (VRTX) United States $116.113B 0.00
GSK (GSK) United Kingdom $79.744B 9.55
CSL (CSLLY) Australia $76.254B 0.00
Regeneron Pharmaceuticals (REGN) United States $57.752B 14.02
Alnylam Pharmaceuticals (ALNY) United States $41.993B 0.00
Argenex SE (ARGX) Netherlands $33.123B 90.41
BioNTech SE (BNTX) Germany $25.845B 0.00
Royalty Pharma (RPRX) United States $20.173B 8.52
Biogen (BIIB) United States $19.059B 8.22
Insmed (INSM) United States $18.520B 0.00
Illumina (ILMN) United States $15.537B 29.47
Genmab (GNMSF) Denmark $13.545B 13.85
Incyte (INCY) United States $13.304B 101.07
Genmab (GMAB) Denmark $13.299B 14.92
Exelixis (EXEL) United States $11.896B 20.19
Moderna (MRNA) United States $11.096B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.776B 17.50
QIAGEN (QGEN) Netherlands $10.717B 20.85
Ascendis Pharma (ASND) Denmark $10.515B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.300B 0.00
Blueprint Medicines (BPMC) United States $8.288B 0.00
Bio-Techne Corp (TECH) United States $8.164B 30.46
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.703B 0.00
Roivant Sciences (ROIV) United Kingdom $7.437B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.220B 0.00
Repligen (RGEN) United States $7.104B 79.52
Revolution Medicines (RVMD) United States $6.871B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Legend Biotech (LEGN) United States $6.669B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.622B 6.50
Halozyme Therapeutics (HALO) United States $6.521B 12.48
Guardant Health (GH) United States $6.282B 0.00
TG Therapeutics (TGTX) United States $5.620B 147.50
Nuvalent (NUVL) United States $5.602B 0.00
Telix Pharmaceuticals (TLX) Australia $5.441B 0.00
Axsome Therapeutics (AXSM) United States $5.070B 0.00
Alkermes (ALKS) Ireland $4.780B 12.82
Anbio Biotechnology (NNNN) Germany $4.524B 0.00
ADMA Biologics Inc (ADMA) United States $4.269B 31.93
Vaxcyte (PCVX) United States $4.249B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.190B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.163B 0.00
Zealand Pharma (ZLDPF) Denmark $4.102B 0.00
Akero Therapeutics (AKRO) United States $4.098B 0.00
Cytokinetics (CYTK) United States $4.018B 0.00
Krystal Biotech (KRYS) United States $4.017B 30.96
Zai Lab (ZLAB) China $3.907B 0.00
PTC Therapeutics (PTCT) United States $3.851B 6.70
Merus (MRUS) Netherlands $3.645B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.575B 31.41
Arcellx (ACLX) United States $3.565B 0.00
SpringWorks Therapeutics (SWTX) United States $3.541B 0.00
Avidity Biosciences (RNA) United States $3.430B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.428B 0.00
Ascentage Pharma Group - (AAPG) China $3.397B 0.00
Scholar Rock Holding (SRRK) United States $3.205B 0.00
Protagonist Therapeutics (PTGX) United States $3.112B 66.95
Viking Therapeutics (VKTX) United States $2.995B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.984B 0.00
Kymera Therapeutics (KYMR) United States $2.894B 0.00
Metsera (MTSR) United States $2.824B 0.00
Immunovant (IMVT) United States $2.760B 0.00
Alvotech (ALVO) Luxembourg $2.734B 15.64
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.686B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.462B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.397B 0.00
ImmunityBio (IBRX) United States $2.268B 0.00
Apellis Pharmaceuticals (APLS) United States $2.246B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.222B 0.00
Twist Bioscience (TWST) United States $2.202B 0.00
Ligand Pharmaceuticals (LGND) United States $2.172B 0.00
Vericel (VCEL) United States $2.094B 1386.67
Bavarian Nordic (BVNRY) Denmark $2.088B 11.03
Recursion Pharmaceuticals (RXRX) United States $2.085B 0.00
Apogee Therapeutics (APGE) United States $2.038B 0.00
Denali Therapeutics (DNLI) United States $2.027B 0.00
CG Oncology (CGON) United States $2.009B 0.00
NovoCure (NVCR) Jersey $1.993B 0.00
Agios Pharmaceuticals (AGIO) United States $1.991B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.988B 0.00
Certara (CERT) United States $1.869B 34.91
IDEAYA Biosciences (IDYA) United States $1.850B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.839B 12.23
Belite Bio (BLTE) United States $1.820B 0.00
Amicus Therapeutics (FOLD) United States $1.798B 194.67
GRAIL (GRAL) United States $1.771B 0.00
Disc Medicine (IRON) United States $1.771B 0.00
Beam Therapeutics (BEAM) United States $1.763B 0.00
Sarepta Therapeutics (SRPT) United States $1.740B 0.00
Adaptive Biotechnologies (ADPT) United States $1.700B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.680B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.650B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.639B 0.00
Mesoblast (MESO) Australia $1.549B 0.00
Vera Therapeutics (VERA) United States $1.467B 0.00
Biohaven (BHVN) United States $1.425B 0.00
89BIO (ETNB) United States $1.420B 0.00
Celldex Therapeutics (CLDX) United States $1.408B 0.00
ANI Pharmaceuticals (ANIP) United States $1.377B 14.19
Janux Therapeutics (JANX) United States $1.374B 0.00
Edgewise Therapeutics (EWTX) United States $1.349B 0.00
Travere Therapeutics (TVTX) United States $1.306B 0.00
CureVac (CVAC) Germany $1.214B 5.88
Dynavax Technologies (DVAX) United States $1.208B 71.86
Viridian Therapeutics (VRDN) United States $1.181B 0.00
Structure Therapeutics (GPCR) United States $1.176B 0.00
MannKind (MNKD) United States $1.088B 22.38
Pacira BioSciences (PCRX) United States $1.076B 10.24
Novavax (NVAX) United States $1.071B 2.49
AbCellera Biologics (ABCL) Canada $1.042B 0.00
Liquidia Technologies (LQDA) United States $1.026B 0.00
Intellia Therapeutics (NTLA) United States $1.023B 0.00
WAVE Life Sciences (WVE) Singapore $1.013B 0.00
Niagen Bioscience (NAGE) United States $1.009B 142.33
BGM Group (BGM) China $1.003B 0.00
NeoGenomics (NEO) United States $0.954B 0.00
Spyre Therapeutics (SYRE) United States $0.934B 0.00
MiMedx (MDXG) United States $0.919B 22.21
Pharvaris (PHVS) Netherlands $0.902B 0.00
Mineralys Therapeutics (MLYS) United States $0.893B 0.00
Nurix Therapeutics (NRIX) United States $0.893B 0.00
Arcus Biosciences (RCUS) United States $0.885B 0.00
Praxis Precision Medicines (PRAX) United States $0.879B 0.00
Geron (GERN) United States $0.879B 0.00
Oric Pharmaceuticals (ORIC) United States $0.864B 0.00
Zymeworks (ZYME) United States $0.863B 0.00
LENZ Therapeutics (LENZ) United States $0.846B 0.00
Oculis Holding AG (OCS) Switzerland $0.828B 0.00
Cogent Biosciences (COGT) United States $0.822B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Sionna Therapeutics (SION) United States $0.801B 0.00
CorMedix Inc (CRMD) United States $0.800B 53.59
Anavex Life Sciences (AVXL) United States $0.797B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
UniQure (QURE) Netherlands $0.766B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.759B 0.00
Immunome (IMNM) United States $0.737B 0.00
Pharming Group (PHAR) Netherlands $0.729B 0.00
ArriVent BioPharma (AVBP) United States $0.715B 0.00
Vir Biotechnology (VIR) United States $0.706B 0.00
Replimune (REPL) United States $0.705B 0.00
Gyre Therapeutics (GYRE) United States $0.699B 186.50
Immatics (IMTX) Germany $0.673B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.670B 0.00
Trevi Therapeutics (TRVI) United States $0.669B 0.00
AnaptysBio (ANAB) United States $0.665B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.665B 0.00
GH Research (GHRS) Ireland $0.662B 0.00
Nuvation Bio (NUVB) United States $0.660B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.657B 0.00
Jyong Biotech (MENS) $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sana Biotechnology (SANA) United States $0.638B 0.00
Stoke Therapeutics (STOK) United States $0.636B 14.75
Phathom Pharmaceuticals (PHAT) United States $0.618B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.609B 0.00
Arbutus Biopharma (ABUS) United States $0.609B 0.00
Urogen Pharma (URGN) United States $0.600B 0.00
Cidara Therapeutics (CDTX) United States $0.599B 0.00
Tango Therapeutics (TNGX) United States $0.590B 0.00
Castle Biosciences (CSTL) United States $0.587B 39.88
Iovance Biotherapeutics (IOVA) United States $0.581B 0.00
Upstream Bio (UPB) United States $0.580B 0.00
Dianthus Therapeutics (DNTH) United States $0.578B 0.00
Sage Therapeutics (SAGE) United States $0.569B 0.00
Arvinas (ARVN) United States $0.557B 0.00
Keros Therapeutics (KROS) United States $0.542B 0.00
Opthea (OPT) Australia $0.525B 0.00
MeiraGTx Holdings (MGTX) United States $0.521B 0.00
Tyra Biosciences (TYRA) United States $0.516B 0.00
Bicara Therapeutics (BCAX) United States $0.516B 0.00
Maze Therapeutics (MAZE) United States $0.511B 0.00
Myriad Genetics (MYGN) United States $0.510B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.505B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.487B 0.00
Abivax SA (ABVX) France $0.486B 0.00
Kura Oncology (KURA) United States $0.485B 0.00
Celcuity (CELC) United States $0.473B 0.00
Septerna (SEPN) United States $0.472B 0.00
Fortrea Holdings (FTRE) United States $0.472B 13.02
ATyr Pharma (ATYR) United States $0.457B 0.00
Cullinan Therapeutics (CGEM) United States $0.451B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.448B 0.00
Kamada (KMDA) Israel $0.446B 26.76
Cytek Biosciences (CTKB) United States $0.441B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.439B 0.00
Precigen (PGEN) United States $0.428B 0.00
PureTech Health (PRTC) United States $0.414B 0.00
REGENXBIO (RGNX) United States $0.413B 0.00
Rapport Therapeutics (RAPP) United States $0.413B 0.00
MBX Biosciences (MBX) United States $0.388B 0.00
Erasca (ERAS) United States $0.385B 0.00
ITeos Therapeutics (ITOS) United States $0.383B 0.00
Zenas BioPharma (ZBIO) United States $0.382B 0.00
Vigil Neuroscience (VIGL) United States $0.380B 0.00
Rezolute (RZLT) United States $0.378B 0.00
Tectonic Therapeutic (TECX) United States $0.376B 0.00
Eton Pharmaceuticals (ETON) United States $0.376B 0.00
Citius Oncology (CTOR) United States $0.371B 0.00
Fulcrum Therapeutics (FULC) United States $0.369B 0.00
Prime Medicine (PRME) United States $0.358B 0.00
Emergent Biosolutions (EBS) United States $0.358B 0.00
Compass Therapeutics (CMPX) United States $0.357B 0.00
Solid Biosciences (SLDB) United States $0.357B 0.00
Humacyte (HUMA) United States $0.354B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.352B 0.00
Amarin (AMRN) Ireland $0.348B 0.00
Northwest Biotherapeutics (NWBO) United States $0.347B 0.00
Prothena (PRTA) Ireland $0.337B 0.00
Terns Pharmaceuticals (TERN) United States $0.336B 0.00
Absci (ABSI) United States $0.330B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.320B 0.00
Benitec Biopharma (BNTC) United States $0.318B 0.00
Crescent Biopharma (CBIO) United States $0.316B 0.00
XOMA Royalty (XOMA) United States $0.315B 0.00
Aura Biosciences (AURA) United States $0.315B 0.00
Atea Pharmaceuticals (AVIR) United States $0.308B 0.00
Astria Therapeutics (ATXS) United States $0.306B 0.00
Olema Pharmaceuticals (OLMA) United States $0.299B 0.00
Lifecore Biomedical (LFCR) United States $0.295B 0.00
Aardvark Therapeutics (AARD) United States $0.294B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.291B 0.00
DBV Technologies S.A (DBVT) France $0.287B 0.00
Inventiva S.A (IVA) France $0.285B 0.00
Abeona Therapeutics (ABEO) United States $0.285B 0.00
Gossamer Bio (GOSS) United States $0.284B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.284B 57.62
Cartesian Therapeutics (RNAC) United States $0.283B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.277B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.276B 0.00
Neurogene (NGNE) United States $0.274B 0.00
Foghorn Therapeutics (FHTX) United States $0.271B 0.00
Annexon (ANNX) United States $0.271B 0.00
Ocugen (OCGN) United States $0.270B 0.00
Entrada Therapeutics (TRDA) United States $0.270B 8.78
ADC Therapeutics SA (ADCT) Switzerland $0.265B 0.00
Alpha Teknova (TKNO) United States $0.263B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.263B 0.00
Allogene Therapeutics (ALLO) United States $0.258B 0.00
Palvella Therapeutics (PVLA) United States $0.251B 0.00
Sagimet Biosciences (SGMT) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.244B 0.00
Candel Therapeutics (CADL) United States $0.243B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Verastem (VSTM) United States $0.236B 0.00
Cardiff Oncology (CRDF) United States $0.234B 0.00
MaxCyte (MXCT) United States $0.231B 0.00
Adherex Technologies (FENC) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Adocia (ADOCY) France $0.216B 0.00
Inhibrx Biosciences (INBX) United States $0.212B 0.13
ProQR Therapeutics (PRQR) Netherlands $0.211B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.210B 0.00
SELLAS Life Sciences (SLS) United States $0.208B 0.00
Tvardi Therapeutics (TVRD) United States $0.207B 0.00
ScPharmaceuticals (SCPH) United States $0.207B 0.00
Monopar Therapeutics (MNPR) United States $0.205B 0.00
BioStem Technologies (BSEM) $0.203B 8.27
Design Therapeutics (DSGN) United States $0.200B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.200B 0.00
Codexis (CDXS) United States $0.199B 0.00
AC Immune (ACIU) Switzerland $0.199B 0.00
Kodiak Sciences (KOD) United States $0.198B 0.00
CARGO Therapeutics (CRGX) United States $0.193B 0.00
I-Mab (IMAB) United States $0.191B 0.00
CytomX Therapeutics (CTMX) United States $0.190B 4.92
GENFIT S.A (GNFT) France $0.189B 0.00
Editas Medicine (EDIT) United States $0.188B 0.00
Bright Minds Biosciences (DRUG) United States $0.187B 0.00
EnGene Holdings (ENGN) Canada $0.185B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.181B 0.00
Vor Biopharma (VOR) $0.179B 0.00
Puma Biotechnology (PBYI) United States $0.178B 4.66
Voyager Therapeutics (VYGR) United States $0.173B 0.00
Innate Pharma S.A (IPHA) France $0.170B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.167B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.165B 0.00
Alumis (ALMS) United States $0.164B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
Compugen (CGEN) Israel $0.154B 0.00
DiaMedica Therapeutics (DMAC) United States $0.153B 0.00
Nuvectis Pharma (NVCT) United States $0.153B 0.00
Anika Therapeutics (ANIK) United States $0.151B 0.00
Molecular Partners AG (MOLN) Switzerland $0.150B 0.00
BioAge Labs (BIOA) United States $0.148B 0.00
Alpha Cognition (ACOG) Canada $0.147B 0.00
Ventyx Biosciences (VTYX) United States $0.147B 0.00
Instil Bio (TIL) United States $0.144B 0.00
Alector (ALEC) United States $0.142B 0.00
Black Diamond Therapeutics (BDTX) United States $0.141B 41.33
Cuprina Holdings (Cayman) (CUPR) Singapore $0.139B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Agenus (AGEN) United States $0.133B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Seer (SEER) United States $0.129B 0.00
Neumora Therapeutics (NMRA) United States $0.129B 0.00
Sangamo Therapeutics (SGMO) United States $0.125B 0.00
Immuneering (IMRX) United States $0.124B 0.00
Elicio Therapeutics (ELTX) United States $0.124B 0.00
Nkarta (NKTX) United States $0.121B 0.00
Rapt Therapeutics (RAPT) United States $0.121B 0.00
Greenwich LifeSciences (GLSI) United States $0.121B 0.00
Actuate Therapeutics (ACTU) United States $0.120B 0.00
Kyverna Therapeutics (KYTX) United States $0.120B 0.00
Caribou Biosciences (CRBU) United States $0.116B 0.00
Skye Bioscience (SKYE) United States $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
TuHURA Biosciences (HURA) United States $0.108B 0.00
C4 Therapeutics (CCCC) United States $0.107B 0.00
Genelux (GNLX) United States $0.107B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.106B 0.00
Theratechnologies (THTX) Canada $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
HilleVax (HLVX) United States $0.101B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.101B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.101B 0.00
Contineum Therapeutics (CTNM) United States $0.100B 0.00
Tenaya Therapeutics (TNYA) United States $0.098B 0.00
BeyondSpring (BYSI) United States $0.098B 0.00
XBiotech (XBIT) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
Seres Therapeutics (MCRB) United States $0.093B 0.00
Nautilus Biotechnology (NAUT) United States $0.092B 0.00
IO Biotech (IOBT) Denmark $0.091B 0.00
OKYO Pharma (OKYO) $0.088B 0.00
Coherus Oncology (CHRS) United States $0.088B 0.00
Whitehawk Therapeutics (WHWK) United States $0.088B 0.00
Elutia (ELUT) United States $0.088B 0.00
Adagene (ADAG) China $0.087B 0.00
Invivyd (IVVD) United States $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.086B 0.00
Cellectis S.A (CLLS) France $0.086B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.086B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
Forte Biosciences (FBRX) United States $0.082B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Cabaletta Bio (CABA) United States $0.079B 0.00
TELA Bio (TELA) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
Inovio Pharmaceuticals (INO) United States $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
Pliant Therapeutics (PLRX) United States $0.072B 0.00
Zura Bio (ZURA) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.071B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Quince Therapeutics (QNCX) United States $0.069B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.067B 0.00
Immunic (IMUX) United States $0.066B 0.00
Akoya Biosciences (AKYA) United States $0.066B 0.00
Biomea Fusion (BMEA) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
MediciNova (MNOV) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.062B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Repare Therapeutics (RPTX) Canada $0.061B 0.00
Alto Neuroscience (ANRO) United States $0.060B 0.00
Connect Biopharma Holdings (CNTB) United States $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
VistaGen Therapeutics (VTGN) United States $0.059B 0.00
Sutro Biopharma (STRO) United States $0.057B 0.00
Senti Biosciences (SNTI) United States $0.057B 0.00
Quantum Biopharma (QNTM) Canada $0.056B 0.00
Opus Genetics (IRD) United States $0.056B 0.00
PDS Biotechnology (PDSB) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
CervoMed (CRVO) United States $0.052B 0.00
Cue Biopharma (CUE) United States $0.051B 0.00
Adicet Bio (ACET) United States $0.051B 0.00
INmune Bio (INMB) United States $0.049B 0.00
Celularity (CELU) United States $0.049B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Renovaro (RENB) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
RenovoRx (RNXT) United States $0.046B 0.00
Precision BioSciences (DTIL) United States $0.046B 0.00
Annovis Bio (ANVS) United States $0.045B 0.00
Applied Therapeutics (APLT) United States $0.045B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
ABVC BioPharma (ABVC) United States $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Exicure (XCUR) United States $0.039B 0.00
Pluri (PLUR) Israel $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Artiva Biotherapeutics (ARTV) United States $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
PepGen (PEPG) United States $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.036B 0.00
Clene (CLNN) United States $0.035B 0.00
Mersana Therapeutics (MRSN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Radiopharm Theranostics - (RADX) Australia $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.030B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dyadic (DYAI) United States $0.029B 0.00
CAMP4 Therapeutics (CAMP) United States $0.027B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.026B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Femasys (FEMY) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Passage Bio (PASG) United States $0.024B 0.00
ALX Oncology Holdings (ALXO) United States $0.023B 0.00
FibroBiologics (FBLG) United States $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Curis (CRIS) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
CalciMedica (CALC) United States $0.022B 0.00
Generation Bio (GBIO) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
NextCure (NXTC) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Equillium (EQ) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
GeoVax Labs (GOVX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
IN8bio (INAB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
UNITY Biotechnology (UBX) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
HCW Biologics (HCWB) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00